Introduction
Primary malignant tumors of the trachea are rare in both dogs and cats. 1 Primary tracheal tumors can be very difficult to diagnose in practice, often requiring specialized diagnostic equipment such as tracheobronchoscopy and computed tomography (CT). Tumors that have been reported in the feline trachea include lymphosarcoma, adenocarcinoma, squamous cell carcinoma, carcinoma, and seromucinous carcinoma. [2] [3] [4] [5] [6] [7] [8] [9] There are 11 reports of feline tracheal lymphosarcoma in the veterinary literature, making it the most commonly reported tracheal neoplasm. [2] [3] [4] [5] [6] [7] Notwithstanding, there is no standard treatment of feline tracheal lymphoma.
Treatments that have been used include systemic chemotherapy, surgery, and radiation therapy, either alone or in combination. 2, [4] [5] [6] Combination chemotherapy therapy used for feline lymphoma is frequently some variation of the University of Madison Wisconsin (UMW) protocol. [10] [11] [12] The largest case series of primary intratracheal lymphoma included four cats. 5 The cats ranged in age from 4 to 10 yr old.
Two cats were treated with radiation therapy after experiencing adverse events subsequent to chemotherapy and were clinically normal 8 and 17 mo after radiation therapy. A third cat was treated with combination chemotherapy (vincristine, cyclophosphamide, doxorubicin, and prednisone) and was clinically normal 19 mo after starting therapy. The fourth cat was treated with prednisolone and methylprednisolone acetate and was clinically normal for 35 days, at which time the cat became dyspneic and was euthanized. This report describes the clinical presentation, diagnosis (including pre-and posttreatment CT imaging), treatment, and outcome of a cat with intratracheal lymphoma. On physical examination at OSU, there was an increased inspiratory effort (extrathoracic obstructed airway breathing pattern)
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with inspiratory wheezes bilaterally on thoracic auscultation.
The cat had severe periodontal disease, but the remainder of the physical examination was normal. A CBC revealed only a moderate lymphopenia (582 lymphocytes/mL; reference range, 1,200-1,800/mL), and the serum biochemistry profile was normal. Thoracic radiographs revealed normal heart and lungs, but the narrowing of the trachea at the thoracic inlet initially described by the referring veterinarian remained ( Figure 1 ). An and tachypnea) and the owners elected to pursue chemotherapy.
The cat was placed in an oxygen cage in the ICU and the CBC and serum biochemistry profile were repeated before initiating chemotherapy. A mild mature neutrophilia (9,918 neutrophils/mL; reference range, 2,500-8,500/mL), mild lymphopenia (1,026 lymphocytes/mL; reference range, 1,200-8,000/mL), and slightly increased albumin (4.1 g/dL; reference range, 2.5-3.9 g/dL) were noted, consistent with stress and mild dehydration. The UMW 6 mo feline lymphoma protocol was selected and induction using L-asparaginase j (400 U/kg subcutaneously), vincristine k (0.5 mg/m 2 IV), and prednisolone (2 mg/kg PO q 24 hr 3 7 days) was initiated. [10] [11] [12] Within 24 hr of the first treatment, the cat was breathing normally and was removed from the oxygen cage.
For the duration of the chemotherapy protocol, a CBC was performed before each treatment and renal values (blood urea nitrogen [BUN], creatinine, urine specific gravity) were obtained One month after completion of chemotherapy, thoracic radiographs, tracheal CT, and dental prophylaxis were performed under general anesthesia. Thoracic radiographs were unremarkable ( Figure 6 ), and the trachea appeared normal on CT ( Figures   7A, B) . Twenty-one months after completion of the 6 mo combination chemotherapy protocol, the cat had no respiratory abnormalities and remained clinically normal.
Discussion
Lymphoma is a common mesenchymal neoplasm of cats.
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In FeLV-negative cats, the gastrointestinal system is the most commonly affected site. Other sites include the mediastinum, (especially in younger FeLV serologically positive cats), lymph nodes, kidneys, nose, eyes, and central nervous system. Lymphoma of the respiratory system (i.e., trachea, bronchi, or lungs) appears to be rare, with lymphoma being the most commonly reported tracheal tumor. 13, 14 In the cat described in this report, thoracic radiographs did not reveal any abnormalities in the lungs.
Although a CT examination of the lungs is more sensitive for detecting small masses, it was not performed in this case and concurrent pulmonary involvement could not be ruled out FIGURE 6 Lateral cervical radiograph at the completion of the 25 wk chemotherapy protocol demonstrating a normal trachea. narrowing of the trachea can also be observed. 3, 6 In one study of cats with laryngeal, laryngotracheal, and tracheal masses, there was a statistically significant correlation (P¼0.0002) with the presence of a soft tissue opacity in the larynx or trachea and a diagnosis of neoplasia. 2 In some cases of lymphoma of the respiratory system, thoracic radiographs might not reveal any abnormalities. 4 In the cat described in this report, a distinct mass was not obvious on the digital radiographs. Rather, only a narrowing of the trachea at the thoracic inlet was obvious. To determine the underlying cause for the tracheal narrowing, CTwas used. There have been no previous reports of CT to evaluate feline tracheal lymphoma. In human medicine, CT is considered superior to thoracic radiographs in detecting abnormalities in the trachea and bronchi. One study reported sensitivity of 66% for thoracic radiographs in detecting tracheal and bronchial disease and sensitivity of 91-97% for CT. 16 In that study, CT was not able to reliably differentiate malignant from benign lesions in humans. 16 Based on the findings in the case described herein and the demonstrated increased sensitivity of CT in human medicine for detecting tracheal lesions, CT should be considered in veterinary patients with signs of inspiratory dyspnea with nonspecific changes on thoracic radiographs.
A metabolic cause for the episode of hypersalivation and vomiting before chemotherapy and hypersalivation before subsequent chemotherapy treatments could not be found in this cat. The cat hypersalivated upon restraint for catheter placement and when the chemotherapy technician was present (the same technician administered the majority of the chemotherapy treatments).
These episodes resemble a condition called anticipatory nausea and vomiting (ANV) that occurs in 25-30% of human chemotherapy patients. 17, 18 There are no published reports of ANV in cats. ANV is characterized by nausea and vomiting before chemotherapy administration and is believed to be a conditioned response. Risk of ANV increases as the number of chemotherapy treatments increases.
Human patients that exhibit nausea and vomiting after chemotherapy are at an increased risk of developing ANV. The cat in this report did not have any reported postchemotherapy vomiting; however, the owners reported that after some treatments (especially vincristine), the cat's appetite was decreased for 1-3 days. It is possible that the cat experienced a mild to moderate degree of nausea after chemotherapy, and this conditioned him to respond to elements associated with chemotherapy administration, such as restraint for catheter placement and the presence of the chemotherapy technician. CT performed 1 mo after completion of chemotherapy revealed complete resolution of the tracheal mass and presumably the lymphoma. Previous case reports of cats treated with combination chemotherapy indicated that survival times could be prolonged to 8 and 19 mo. 5, 6 Based on these previous cases of intratracheal lymphoma, treatment with combination chemotherapy or radiation therapy could result in long-term remission and could even be curative in cats ( Table 1) . The cat described in this report appeared to support this possibility. Further, combination chemotherapy might be a more accessible treatment option for owners due to the limited availability of radiation therapy.
Conclusion
In conclusion, CT should be considered an appropriate and often necessary diagnostic modality in cats with inspiratory dyspnea, 
